Proposal to fund a pangenotypic hepatitis C treatment - glecaprevir and pibrentasvir (Maviret)

20 July 2018 - PHARMAC is seeking feedback on a proposal to fund a pangenotypic treatment for chronic hepatitis C ...

Read more →

Malcolm Turnbull defends insurers’ access to health records

20 July 2018 - Malcolm Turnbull has defended the right of insurance companies to access Australians’ health records, amid privacy ...

Read more →

Don’t let opt out debate shroud potential benefits of My Health Record

19 July 2018 - Australians should not lose sight of the great potential benefits of the My Health Record in ...

Read more →

New Zealand to expand PHARMAC to the Pacific

19 July 2018 - New Zealand is looking at opening up access to its drug buying agency PHARMAC to five Pacific ...

Read more →

Vertex mulls over NHS England’s offer for CF drugs

18 July 2018 - Vertex Pharmaceuticals is considering a final offer from NHS England on funding for its cystic fibrosis ...

Read more →

Private health insurance rankings to give consumers more information about coverage and benchmarks

16b July 2018 - Private health insurance premiums will be ranked in a bid to help consumers figure out exactly ...

Read more →

U.K. health officials make a counteroffer to Vertex for its pricey cystic fibrosis drugs

17 July 2018 - Seeking to break a stalemate over pricey cystic fibrosis drugs, the U.K.’s National Health Service has ...

Read more →

My Health Record: confusion as some Australians shocked they already have one

18 July 2018 - Wes Mountain in Melbourne said he tried to opt out of My Health Record on Monday, ...

Read more →

Health Minister Greg Hunt defends My Health Record amid opt-out faults

16 July 2018 - The rollout of Australia’s electronic health record system has been plagued by delays and technical faults, ...

Read more →

My Health Record opt-out period begins, but privacy concerns remain

16 July 2018 - The Federal Government's digital health agency has moved to reassure Australians that their online My Health ...

Read more →

2018 October price disclosure cycle - indicative prices

16 July 2018 - Indicative 1 October 2018 prices resulting from the 2018 October cycle of price disclosure have now been ...

Read more →

NICE backs AZ’s asthma biologic Fasenra

16 July 2018 - AstraZeneca’s biologic Fasenra will likely be funded on the NHS as a treatment for people with ...

Read more →

My Health Record opens new era for health care

16 July 2018 - The potential of My Health Record to transform the health care system in Australia will depend ...

Read more →

$250 million investment in life changing cancer medicines

15 July 2018 - The Australian Government will invest $250 million to make four life-changing cancer medicines available to thousands of ...

Read more →

PHARMAC work in funding medicines for rare disorders progressing

16 July 2018 - PHARMAC is progressing work aimed at improving funded access to medicines for rare disorders. ...

Read more →